Clearsens, Inc.

Raleigh, NC

UEI
VCS7SFYN7NS3
CAGE
8C2L0
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Partners I, 1017 Main Campus Dr #2312, Raleigh, NC 27606, USA
Website
clearsens.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Information Technology
  2. Semiconductors & Semiconductor Equipment
  3. Semiconductors
SIC code
36 Electronic & Other Electric Equipment
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $289,679
FY2025 $838,295
FY2024 $249,245
FY2023 $750,000

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of the Navy $289,679

Contract awards

Award Agency Obligated Awarded
Sbir 1 compact wearable ultrasonic monitoring system for in-suit venous gas emboli detection 80NSSC25C0168 Shared Services Center $148,615
Research and development N6833523C0037 Naval Air Warfare Center (NAVAIR) $1,978,604
Topic N21A-T013 N6833521C0363 Naval Air Warfare Center (NAVAIR) $239,745

Similar vendors

About the company

Clearsens, Inc. is a for-profit corporate entity based in Raleigh, North Carolina, that specializes in advanced research and development within medical technology and monitoring systems. Registered in SAM.gov since June 2019, the company is a small business manufacturer focused on innovative technological solutions, particularly in medical device development and ultrasonic monitoring technologies. The company has demonstrated capability in securing federal research contracts, specifically through Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which indicate its commitment to cutting-edge technological innovation.

The company has secured multiple federal contract awards primarily from defense and civilian agencies, with a specific focus on research and development projects. The Office of Naval Research has been a key funding agency, awarding Clearsens, Inc. three significant contracts: a STTR Phase I contract valued at $239,745.00 in June 2021, a STTR Phase II contract worth $1,978,604.00 in January 2023, and a more recent SBIR Phase I contract for $149,615.00 in September 2025. These contracts are consistently designated as Total Small Business set-asides and involve advanced research efforts, including the development of a compact, wearable ultrasonic monitoring system for detecting venous gas emboli in-suit. The contracts span research and development projects with completion dates ranging from December 2022 to February 2027, highlighting the company's ongoing technological innovation in medical monitoring and detection systems.

Quick answers

Is Clearsens, Inc. registered in SAM.gov?

Yes. Clearsens, Inc.'s SAM.gov registration is active through April 6, 2027.

What is Clearsens, Inc.'s CAGE code?

Clearsens, Inc.'s CAGE code is 8C2L0, and its Unique Entity ID (UEI) is VCS7SFYN7NS3.

How much has Clearsens, Inc. received in federal contracts?

Federal contracts obligated $838,295 to Clearsens, Inc. in fiscal year 2025 and $2,127,219 in fiscal years 2023 through 2027.

What is Clearsens, Inc.'s most recent federal award?

Clearsens, Inc.'s most recent federal contract award is Sbir 1 compact wearable ultrasonic monitoring system for in-suit venous gas emboli detection (80NSSC25C0168), from Shared Services Center, on September 29, 2025.

On GovTribe

See Clearsens, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe